President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
Category: Regulation and Deregulation of Industry
-
Key Justices Cast a Skeptical Eye on Trump’s Tariffs
The Supreme Court is considering whether the president acted legally when he used a 1977 emergency statute to impose tariffs on scores of countries.
-
Trump Aides Raise Recession Fears, and Point Fingers at the Fed
Treasury Secretary Scott Bessent said some sectors were in a recession as he argued for more interest rate cuts.
-
The Workers Left Out of Trump’s Drug-Manufacturing Renaissance
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.
-
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
-
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
-
F.D.A. Drug Unit Chief Is Placed on Leave, and Cites a ‘Toxic’ Environment
The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.
-
Can Paul Atkins ‘Make I.P.O.s Great Again’?
The chair of the Securities and Exchange Commission has a plan to reverse the decline in public listings. His critics say he’s taking swings at the wrong target.
-
Fed Governor Defends Call for Big Rate Cuts
In a wide-ranging interview, Stephen I. Miran discussed why he thinks concerns about inflation are overblown and his worries about the economy if the Federal Reserve does not rapidly lower interest rates. Here is a full transcript.
-
How to Shop for Obamacare When Subsidies Are in Limbo
Enrollment for A.C.A. health coverage begins Nov. 1, with some staggering price increases. Here is a guide to help you choose a plan while Congress is at an impasse over tax credits.
-
Fed Risks a Recession if It Doesn’t Cut Rates Rapidly, Stephen Miran Warns
Stephen I. Miran, the newest member of the central bank’s Board of Governors, thinks some of his colleagues are too worried about inflation.